| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EBS
|
121.30 | 47.1B | 13.15 | 1.75 | — | — | — | 72 | 73 | 182.39 | +34.7% | 91 | 2.26 |
|
BG
|
179.80 | 13.8B | 15.76 | 2.86 | — | — | — | 65 | 60 | 177.24 | -1.0% | 92 | 3.67 |
|
RBI
|
63.80 | 21.0B | 43.90 | 0.96 | — | — | — | 46 | 36 | 62.42 | -1.3% | 55 | 0.99 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.